Source: Virtual Congress 2021 – Therapy of pulmonary hypertension



Rating:

Share or cite this content

Citations should be made in the following way:
L. Spikes (Kansas City, United States of America), S. Shapiro (Los Angeles, United States of America), R. Restrepo-Jaramillo (Tampa, United States of America), J. Joly (Birmingham, United States of America), T. Shah (Dallas, United States of America), J. Scoggin (RTP, United States of America), L. Edwards (RTP, United States of America), P. Smith (RTP, United States of America). BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso. 1928

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients. Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection Year: 2019 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on a Functional Respiratory Imaging (FRI) Model Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Cost Effectiveness Comparison of a Dry Powder Inhaler to a Metered Dose Inhaler plus Valved Holding Chamber based on an In-Vitro Drug Delivery Model Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies Year: 2020 Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 FENO Guided Therapy in Asthma: A Non-inferiority Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Monitored Anesthesia Care with Dexmedetomidine in Patients Undergoing Pleuroscopy: Effect on Oxygenation and Respiratory Function. A Prospective, Single-center Study. Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018 Effect of High-Flow Oxygen on Exercise Performance In COPD. A Randomized Crossover Trial. Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Short-term Impact of Lung Flute and Inspiratory Muscle Trainer on Pulmonary Functions and Functional Capacity in COPD from a Low Middle Income Country : A Pilot Randomized Control Trial. Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kd) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block. Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 The ARROW Study: A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Study of Selonsertib in Subjects with Pulmonary Arterial Hypertension Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Late Breaking Abstract - Comparison of High Flow Nasal Cannula with Noninvasive Ventilation in Facilitating Weaning COPD From Invasive Ventilation: A Prospective Randomized Controlled Study Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD? Year: 2018 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021